The beat was driven by margin expansion and cost discipline rather than revenue acceleration. With organic revenue growth of only 0.7% and BSI organic revenue declining 0.4%, the top-line story remains sluggish. Monitor the Q4 earnings call for signs of the expected FY27 growth acceleration, particularly in US academic demand and BSI bookings conversion.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 4 $63.79entry
- T+1 · 14h ago −8.98%α −4.57% · $58.06
- T+5 · in 5d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Bruker reported Q3 2026 revenue of $874.0M (+1.6% YoY) and non-GAAP EPS of $0.56 (+24.4% YoY), beating consensus estimates of $865.2M and $0.42. The company reconfirmed its FY2026 organic revenue growth and non-GAAP EPS guidance, while narrowing the reported revenue range to $3.52-$3.56B. Strong margin expansion (non-GAAP operating margin up 400 bps to 16.3%) and a fifth consecutive quarter of BSI book-to-bill >1.0x were positive, but overall revenue growth remained modest with organic revenue up only 0.7% and BSI organic revenue declining 0.4%.
Key Financial Metrics
Key Facts
- Q3 2026 revenue $874.0M, up 1.6% YoY, organic growth 0.7%
- Q3 2026 non-GAAP diluted EPS $0.56, up 24.4% YoY from $0.45
- Q3 2026 GAAP diluted loss per share $(0.81) vs $(0.41) in Q3 2025, includes $174.5M goodwill impairment
- Non-GAAP operating margin 16.3%, up 400 bps YoY from 12.3%
- BSI organic bookings and backlog both up mid-single digits % year-to-date
- Fifth consecutive quarter of BSI book-to-bill greater than 1.0x
- FY2026 guidance reconfirmed: organic revenue growth 1-2%, non-GAAP EPS $2.10-$2.15
- FY2026 revenue guidance narrowed to $3.52-$3.56B (from $3.54-$3.57B) on currency changes
- Q3 2026 free cash flow $96.7M vs $(54.1)M in Q3 2025
- Cash and cash equivalents $119.7M at Sep 30, 2026, down from $298.8M at Dec 31, 2025
Financial Impact
Q3 revenue $874.0M vs consensus $865.2M (beat); non-GAAP EPS $0.56 vs consensus $0.42 (beat of +33.3%)
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Bruker BIOS | $397.2M | +1.5% |
| Bruker MID | $133.6M | +2.6% |
| Bruker Nano | $263.1M | -1.3% |
| BEST | $82.1M | +11.2% |
Risk Factors
- Organic revenue growth remains weak at 0.7% overall and -0.4% for BSI segment
- GAAP results continue to show losses driven by large goodwill impairment charges ($174.5M in Q3, $309.4M YTD)
- Cash balance declined significantly from $298.8M to $119.7M year-to-date
- FY2026 revenue guidance range narrowed downward on unfavorable currency translation
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-446176 |
| Document: brkr-20261104.htm | 0001193125-26-446176 |
| Document: 0001193125-26-446176-index-headers.html | 0001193125-26-446176 |
| Document: 0001193125-26-446176-index.html | 0001193125-26-446176 |
| Document: 0001193125-26-446176.txt | 0001193125-26-446176 |
| 8-K Data (Synthetic) | 0001193125-26-446176 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 5, 2026 today | 8-K | $61.94 | awaiting T+60 | awaiting T+60 | $63.79 (+2.99%) |
Nov 4, 2026 1d ago | 8-K | $63.79 | awaiting T+60 | awaiting T+60 | $63.79 (+0.00%) |
Oct 29, 2026 7d ago | 8-K | $57.07 | awaiting T+60 | awaiting T+60 | $63.79 (+11.78%) |
Oct 27, 2026 9d ago | Institutional Cluster | $62.00 | awaiting T+60 | awaiting T+60 | $63.79 (+2.89%) |
Aug 18, 2026 11w ago | Insider Cluster | $58.60 | awaiting T+60 | awaiting T+60 | $63.79 (+8.85%) |
Aug 14, 2026 11w ago | 8-K | $57.67 | awaiting T+60 | awaiting T+60 | $63.79 (+10.61%) |
Aug 4, 2026 13w ago | 8-K | $50.30 $60.74 | ▲ +20.76% | ▲ +20.97% | $63.79 (+26.82%) |
Jun 11, 2026 21w ago | Institutional Cluster | $55.18 $58.50 | ▲ +6.02% | ▲ +1.62% | $63.79 (+15.60%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers